EP3448416
SEMAGLUTIDE IN CARDIOVASCULAR CONDITIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.4.2017EP published:
10.8.2022EP application number:
17721109.1
EPO information:
European Patent Register
Max expiry date:
27.4.2037
Title in English:
SEMAGLUTIDE IN CARDIOVASCULAR CONDITIONSLanguage of the patent:
English
Timeline
Today
28.4.2017EP application
10.8.2022EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880 Bagsværd, DK
Inventor
Name:
HANSEN, Oluf Kristian HøjbjergAddress:
2880 Bagsværd, DK
Priority
Number:
16167458Date:
28.4.2016Country:
EP
Number:
16188262Date:
12.9.2016Country:
EP
Classification
Categories:
A61K 38/26, A61P 3/10, A61P 9/00